Caorui Lin
Impact in
-
- MicroRNA in disease regulation
-
- Extracellular vesicles in disease
- Muscle Physiology and Disorders
- RNA Interference and Gene Delivery
Papers in
-
- Muscle Physiology and Disorders 8
- RNA Interference and Gene Delivery 4
- Extracellular vesicles in disease 3
- Epidemiology 11
- Hepatitis B Virus Studies 10
- Liver Disease Diagnosis and Treatment 9
- Co-authors
- HaiFang Yin (10 shared papers)Ning Ran (7 shared papers)Xianjun Gao (4 shared papers)Mengyuan Geng (3 shared papers)Xue Dong (1 shared paper)Gang Han (9 shared papers)Yiqi Seow (4 shared papers)Qishui Ou (10 shared papers)
- Journals
- Molecular Therapy — Nucleic Acids (3 papers)Gut (2 papers)EMBO Molecular Medicine (2 papers)Molecular Therapy (1 paper)International Journal of Medical Microbiology (1 paper)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Caorui Lin
22 papers receiving 286 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 53
- Molecular Biology 212
- Aging 5
- Hepatology 22
- Genetics 17
Countries citing papers authored by Caorui Lin
This map shows the geographic impact of Caorui Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caorui Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caorui Lin more than expected).
Fields of papers citing papers by Caorui Lin
This network shows the impact of papers produced by Caorui Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caorui Lin. The network helps show where Caorui Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Caorui Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 82 | |
| 2 | 2022 | 51 | |
| 3 | 2020 | 31 | |
| 4 | 2016 | 16 | |
| 5 | 2024 | 15 | |
| 6 | 2022 | 11 | |
| 7 | 2018 | 10 | |
| 8 | 2020 | 10 | |
| 9 | 2024 | 9 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 7 | |
| 12 | 2022 | 7 | |
| 13 | 2019 | 7 | |
| 14 | 2022 | 7 | |
| 15 | 2022 | 6 | |
| 16 | 2022 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2022 | 2 | |
| 19 | 2023 | 1 | |
| 20 | 2024 | 1 |
About Caorui Lin
Caorui Lin is a scholar working on Molecular Biology, Epidemiology, Hepatology, Surgery and Rheumatology, having authored 23 papers that have together received 291 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (10 papers), Liver Disease Diagnosis and Treatment (9 papers), Muscle Physiology and Disorders (8 papers), Hepatitis C virus research (7 papers), RNA Interference and Gene Delivery (4 papers), Tissue Engineering and Regenerative Medicine (3 papers), Extracellular vesicles in disease (3 papers) and Telomeres, Telomerase, and Senescence (2 papers). The work is most often cited by research in Cancer Research (53 citations), Molecular Biology (212 citations), Aging (5 citations), Hepatology (22 citations) and Genetics (17 citations). Caorui Lin has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include HaiFang Yin, Ning Ran, Xianjun Gao, Mengyuan Geng, Xue Dong, Gang Han, Yiqi Seow, Qishui Ou, Tianbin Chen and Xianfu Yi. Their work appears in journals such as Molecular Therapy — Nucleic Acids, Gut, EMBO Molecular Medicine, Molecular Therapy and International Journal of Medical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.